5-ALA/SFC Mitigates Tau Toxicity via Lowering Oxidative Stress in a Drosophila Model of Tau Toxicity
Life · 24.04.2026 · 16 (5) · 725
DOI: 10.3390/life16050725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 24.04.2026. Verfasst von Arisa Tamura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, Hachioji, Tokyo 192-0397, Japan. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Tokyo Metropolitan University.
Abstract (Originalsprache)
Mitochondrial dysfunctions contribute to the pathogenesis of tauopathies, a group of neurodegenerative diseases with abnormal accumulation of microtubule-associated protein tau. The combination of 5-aminolevulinic acid (5-ALA) and sodium ferrous citrate (SFC) is known to improve mitochondrial functions. Here, we report that 5-ALA combined with SFC (5-ALA/SFC) improves mitochondrial functions and mitigates neurodegeneration in transgenic Drosophila expressing human tau. We found that tau reduces ATP levels, decreases mitochondrial distribution to neurites, and increases mitochondrial reactive oxygen species (ROS). Expression of oxidative phosphorylation (OXPHOS) genes was upregulated, and activities of complexes I and IV were elevated. Feeding 5-ALA/SFC to tau flies lowers oxidative damage without correcting OXPHOS activities or mitochondrial distribution. 5-ALA/SFC treatment suppressed pathological tau phosphorylation and mitigated tau-induced neurodegeneration. These results suggest that 5-ALA/SFC attenuates a neurodegenerative pathway involving tau, mitochondria, and ROS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, Hachioji, Tokyo 192-0397, Japan.
- Division of Pharmaceutical Research, SBI Pharmaceuticals Co., Ltd., Tokyo 106-6020, Japan.
- Department of Biological Sciences, Faculty of Science, Tokyo Metropolitan University, Hachioji, Tokyo 192-0397, Japan.
ORCID-Profile: Emiko Suzuki, Kanae Ando
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Tokyo Metropolitan University
- AMED
- JSPS-Kakenhi Grant-in-Aid for Scientific Research
- SBI Pharmaceuticals Co., Ltd.
- MIYAKO-MIRAI Project of Tokyo Metropolitan University
Zitieren
APA
Tamura, A., Noguchi, M., Nozawa, N., Suzuki, E., & Ando, K. (2026). 5-ALA/SFC Mitigates Tau Toxicity via Lowering Oxidative Stress in a Drosophila Model of Tau Toxicity. Life, 16(5), 725. https://doi.org/10.3390/life16050725
Vancouver
Tamura A, Noguchi M, Nozawa N, Suzuki E, Ando K. 5-ALA/SFC Mitigates Tau Toxicity via Lowering Oxidative Stress in a Drosophila Model of Tau Toxicity. Life. 2026;16(5):725. doi:10.3390/life16050725
BibTeX
@article{Tamura2026,
author = {Tamura, Arisa and Noguchi, Marie and Nozawa, Naoko and Suzuki, Emiko and Ando, Kanae},
title = {5-ALA/SFC Mitigates Tau Toxicity via Lowering Oxidative Stress in a Drosophila Model of Tau Toxicity},
journal = {Life},
year = {2026},
volume = {16},
number = {5},
pages = {725},
doi = {10.3390/life16050725}
}
EUVIMED